New biobank aims to unlock genetic secrets of bipolar disorder
NCT ID NCT07173842
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will create a large biobank of blood samples and detailed health information from 1,000 people with bipolar disorder in Turkey. Researchers will collect DNA and clinical data to better understand the condition and find genetic clues that could improve diagnosis and treatment in the future. No drugs or treatments are tested; the goal is to build a resource for ongoing research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this biobank could help researchers discover genetic markers linked to bipolar disorder, potentially leading to better diagnosis and personalized treatments in the future.
What could go wrong
This is an early-stage observational study that does not test any treatment. It only collects data and samples for future research, so there is no direct benefit to participants, and the hoped-for discoveries may take years or may not happen.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Selçuk University Faculty of Medicine, Department of Psychiatry / NeuroPsyBiT-RTSGD Consortium
Konya, Konya, 42130, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••